Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of ...
Analysts expect the Indianapolis, Indiana-based company to report quarterly earnings at $5.08 per share, up from $2.49 per ...
The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for ...
Thanks to impressive sales growth across multiple therapeutic areas in 2024, Eli Lilly ... the sum the Indianapolis-based drugmaker generated during the same period in 2023. Lilly didn’t mince ...
With a market cap of $799.5 billion, Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading global pharmaceutical firm renowned for its innovative contributions to healthcare.
Eli Lilly has named Winselow Tucker as President and General Manager for India. Tucker will oversee operations, including the Lilly India commercial organization and the Lilly Capability Centre India.
FILE - A sign for Eli Lilly & Co. appears outside their corporate headquarters in Indianapolis on April 26, 2017. (AP Photo/Darron Cummings, File) (Darron Cummings ...
With a market cap of $799.5 billion, Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading global ...
(Reuters) -Eli Lilly on Thursday ... but has been subdued since October when Lilly reported disappointing sales for its highly in-demand treatments. The Indianapolis-based drugmaker reported ...
Read full article: Retrial set to begin Thursday for man accused of estranged wife’s 2017 murder Items can be taken to any of the three drop-off locations from 8 a.m. to 1 p.m. Get ready for ...
Indianapolis-based Eli Lilly and Co. reported fourth-quarter earnings early Thursday morning that topped Wall Street expectations, largely driven by sales of blockbuster medications including ...
Eli Lilly and Company (NYSE:LLY) is a pharmaceutical company, headquartered in Indianapolis, Indiana. The one-month return of Eli Lilly and Company (NYSE:LLY) was 6.98%, and its shares gained 14. ...